|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | A double-blind, place-bocontmlledo randomized phase Ⅲ trial of gemcitabine ( G ) plus bevacizumab(B) versus gemcitabine plus placebo (P)in patients (pts) with advanced pancreatic cancer ( PC ) : A preliminary analysis of Cancer and Leukemia Group B(CALGB) 显示文摘 | Kindler HL Niedzwiecki D Hollis D | 2007 | J Clin Oncol2007，25，18： | 1 |
| 2 | Phase Ⅱ study of flavopiridol in patients with advanced colorectal cancer 显示文摘 | Aklilu M Kindler HL Donehower RC | 2003 | Annals of Oncology2003，14，8： | 1 |
| 3 | Phase II study of pemetrexed with and without folic acid and vitamin B12 as front-line therapy in malignant pleural mesothelioma 显示文摘 | Seagliotti GV Shin DM Kindler HL | 2003 | J Clin Oncol2003，21，8： | 1 |
| 4 | Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma:a double-blind randomised phase 3 study显示文摘 | Kindler HL Ioka T Richel DJ | | 0，，03： | 1 |
| 5 | Malignant pleural mesothelioma显示文摘 | | 2000 | Curr Treat Options Oncol2000，1，4： | 1 |
| 6 | Phase Ⅱ trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer显示文摘 | Kindler HL Friberg G Singh DA | 2005 | J Cl in Oncol2005，23，31： | 1 |
| 7 | Front-line therapy of advanced pancreatic cancer显示文摘 | Kindler HL | 2005 | Semin Oncol2005，32，69： | 1 |
| 8 | Peritoneal mesothelioma: the site of origin matters 显示文摘 | Kindler HL | 2013 | Am Soe Clin Oncol Edue Book2013，33，1： | 1 |
| 9 | Chemotherapy for advanced pancreatic cancer: past, present, and future显示文摘 | Friberg G Kindler HL | 2005 | Curr Oncol Rep2005，7，3： | 1 |
| 10 | Randomized phase Ⅱ trial of cetuximab, bevacizumab, and irinotecan compared with cetuximab and bevacizumab alone in irinoteean-refractory eolorectal cancer: the BOND-2 study 显示文摘 | Saltz LB Lenz HI Kindler HL | 2007 | J Clin Oncol2007，25，29： | 1 |
| 11 | Phase Ⅱ study of pemetrexed with and without folic acid and vitamin B12 as frontline therapy in malignant pleural mesothelioma显示文摘 | Scagliotti GV Shin DM Kindler HL | 2003 | J Clin Oncol2003，21，8： | 1 |
| 12 | Phase II trial of gemcitabine in patients with previously untreated metastatic cancer of the esophagus or gastroesophageal junction 显示文摘 | Sandler AB Kindler HL Einhorn LH | 2000 | Ann Oncol2000，11，9： | 1 |
| 13 | A randomized phase Ⅲ study comparing gemcitabine + pemetrexed versus gemcitabine in patients with locally advanced and metastatic pancreas cancer显示文摘 | Richards DA Kindler HL Oettle H | 2004 | Proc Am Soc Clin Oncol2004，，： | 1 |
| 14 | Erlotinib plus bevacizumab in previously treated patients with malignant pleural mesothelioma显示文摘 | Jackman DM Kindler HL Yeap BY | | 0，，4： | 1 |
| 15 | Phase Ⅱ trial of bevaci zumab plus gemcitahine in patients with advanced pancreatic cancer显示文摘 | Kindler HL Friberg G Singh DA | 2005 | J Clin Oncol2005，23，31： | 1 |
| 16 | Multicenter,doubleblind,placebo-controlled,randomized phase Ⅱ trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma显示文摘 | Kindler HL Karrison TG Gandara DR | | 0，，20： | 1 |
| 17 | Randomized phase Ⅱ trial of cetuxlmab, bevacizumab, and irinotecan compared with cetuxlmab and bevacizumab alone in irinotecan - refractory colorectal cancer: the BOND-2 study显示文摘 | Saltz LB Lenz HJ Kindler HL | 2007 | J Clin 0ncol2007，25，： | 1 |
| 18 | Phase Ⅱ trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer显示文摘 | Kindler HL Friberg G Sillgh DA | 2005 | J Clin Oncol2005，23，31： | 1 |
| 19 | Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study显示文摘 | Kindler HL Ioka T Richel D J | 2011 | Lancet Oncol2011，12，3： | 1 |
| 20 | Phase Ⅱ trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer显示文摘 | Kindler HL Friberg G | 2005 | J Clin Oncol2005，23，31： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员